Evidence map›Paper›PMID 41220030›Full record

ArticleAntimicrobial resistance and infection control2025

Antimicrobial resistance interventions in Latin America and the Caribbean: a scoping review of reported interventions between 2018-2024.

Ernesto Gozzer, Naysha Becerra-Chauca, Mohammed Abba-Aji, Veronika J Wirtz, Gloria Cordoba, Fredy Canchihuamán, Rajeev Peeyush Nagassar, Samantha Yañez-Diaz, Penélope S Brou, Carolina J Delgado-Flores and 1 more

Abstract readScoping Review
In one paragraph

Article in Antimicrobial resistance and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Genomic Diversity and Extended-SpectrumInternational journal of microbiology · 2026
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ernesto GozzerFacultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-5597-8669
Naysha Becerra-ChaucaFacultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Peru. naysha.becerra@upch.pe.ORCID 0000-0001-5706-7351
Mohammed Abba-AjiSchool of Public Health, Boston University, Boston, USA.
Veronika J WirtzSchool of Public Health, Boston University, Boston, USA.ORCID 0000-0002-0863-8768
Gloria CordobaInternational Centre for Antimicrobial Resistance Solutions, Copenhagen, Denmark.ORCID 0000-0002-2609-0468
Fredy CanchihuamánFacultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0001-5165-2357
Rajeev Peeyush NagassarThe Sangre Grande Hospital, The Eastern Regional Health Authority, Sangre Grande, Trinidad and Tobago.ORCID 0000-0001-9946-6035
Samantha Yañez-DiazFacultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0001-7615-1372
Penélope S BrouHealth Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-0689-328X
Carolina J Delgado-FloresGrupo Peruano de Investigación en Medicamentos, Políticas y Servicios Farmacéuticos (GPIMPSF), Universidad Científica del Sur, Lima, Peru.ORCID 0000-0001-9291-9652
Shaffi Fazaludeen KoyaSchool of Public Health, Boston University, Boston, USA.ORCID 0000-0002-1220-5754

Funding

International Centre for Antimicrobial Resistance Solutions (ICARS) ID: 300008
6 · The paper itself

Abstract

backgroundAntimicrobial resistance (AMR) is a critical global health challenge, linked to 4·71 million deaths in 2021 and affecting human health, animals, food, plants, and the environment. This scoping review aims to map out published interventions addressing AMR in the Latin America and Caribbean (LAC) region.

methodsWe searched PubMed, Web of Science, LILACS, and grey literature for articles reporting the implementation of AMR programs, interventions, or policies aimed at tackling AMR published between January 2018 and December 2024.

resultsA total of 82 studies were included, comprising 64 peer-reviewed articles and 18 from grey literature. The majority (n = 75) focused on human health, while a smaller subset (n = 7) addressed animal health. Geographically, most studies were conducted in Brazil (n = 32) and Colombia (n = 22) with only one study in the Caribbean. Antimicrobial stewardship interventions were the primary focus in 50 studies. Only 53 out of 74 studies included an evaluation of the intervention.

conclusionSignificant gaps remain in AMR research in LAC, particularly in animal and environmental health. Rigorous intervention evaluations are needed to generate high-quality evidence for policy and practice. Increased funding for intervention and implementation research across all sectors is crucial to tackling AMR regionally and globally.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipDrug Resistance, BacterialAnimalsCaribbean RegionHumansLatin AmericaAnti-Bacterial AgentsAMRBacterialDrug resistanceLatin AmericaOne healthProgram evaluationReview literature as topic

Identifiers

PMID41220030
PMCPMC12607118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.